Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0314719 (dry eye)
 2,625 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Dry-eye conditions do not represent an etiologically homogeneous clinical picture, and therapy is therefore difficult. Tear substitution by means of artificial tears of various viscosities has been common practice, and the use of highly viscous artificial tears is considered appropriate therapy in many cases of dry eye because of their prolonged contact time on the ocular surface. A clinical study with a gel made of cross-linked polymers of acrylic acid with a high molecular weight (Thilo-Tears) showed that both the subjective and objective effects were good. Clinical parameters and data describing the differences in contact times of the highly viscous preparations and a low-viscosity solution (2% PVP), Schirmer's test, Jones's test, and BUT are described and assessed in detail. Furthermore, an attempt is made to supplement and corroborate the clinical findings and the rationale of using highly viscous solutions by presenting experimental results on the preocular film. In particular, considerations pertaining to the relevance and the formation of the glycocalyx from vesicles of corneal epithelial cells are discussed, and the interaction of the epithelial cell membranes with the preocular film is emphasized.
 ...
PMID:[Tear substitutes. Experimental and clinical observations]. 323 31

A cationic biopolymer, chitosan, is proposed for use in artificial tear formulations. It is endowed with good wetting properties as well as an antibacterial effect that are desirable in cases of dry eye, which is often complicated by secondary infections. Solutions containing 0.5% w/v of a low molecular weight (M(w)) chitosan (160 kDa) were assessed for antibacterial efficacy against E. coli and S. aureus by using the usual broth-dilution technique. The in vitro evaluation showed that concentrations of chitosan as low as 0.0375% still exert a bacteriostatic effect against E. coli. Minimal inhibitory concentration (MIC) values of chitosan were calculated to be as low as 0.375 mg/ml for E. coli and 0.15 mg/ml for S. aureus. Gamma scintigraphic studies demonstrated that chitosan formulations remain on the precorneal surface as long as commonly used commercial artificial tears (Protagent collyrium and Protagent-SE unit-dose) having a 5-fold higher viscosity.
 ...
PMID:Chitosan as tear substitute: a wetting agent endowed with antimicrobial efficacy. 1087 23